Zydus Lifesciences Hits Day Low of Rs 943 Amid Price Pressure

Zydus Lifesciences has experienced a notable decline today, with the stock falling by 3.17% as of November 6, 2025. The stock reached an intraday low of Rs 943, reflecting a decrease of 3.07%. This downward trend marks the second consecutive day of losses for the company, which has seen a total decline of 3.7% over this period. In terms of performance metrics, Zydus Lifesciences has underperformed compared to its sector, lagging by 2.46%. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a challenging market position. Over the past week, Zydus Lifesciences has recorded a 4.46% decline, while its performance over the past month shows a drop of 5.22%. In contrast, the broader market, represented by the Sensex, has shown resilience, trading slightly negative at 83,361.63, but remaining close to its 52-week high. The Sensex has outperformed Zydus Lifesciences across various time frames, highlighting the stock's current struggles in the competitive pharmaceuticals and biotechnology sector.